Depression involved in self-reported prospective memory problems in survivors of breast cancer who have received chemotherapy
- PMID: 31008981
- PMCID: PMC6494378
- DOI: 10.1097/MD.0000000000015301
Depression involved in self-reported prospective memory problems in survivors of breast cancer who have received chemotherapy
Abstract
To investigate the relationship between depression and the self-reported prospective memory (SPM) problems in breast cancer survivors who have received chemotherapy.Sixty-three breast cancer patients were administered with self-rating depression scale (SDS) and the prospective memory questionnaire as part of extensive neuropsychological assessments before and after chemotherapy. The performance of SDS and SPM were compared, with the level of significance set at P < .05.Compared with the group before chemotherapy, there is a significant difference on the SPM score (t = 6.069, P = .000) in breast cancer patients after chemotherapy. Further, there is also a significant difference on the SPM score (t = -4.348, P = .000) between the patients with and without depression group after chemotherapy.The present result indicated that the depression in breast cancer survivors after chemotherapy may be involved in their chemotherapy-induced SPM impairment.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.Psychooncology. 2018 Jan;27(1):171-177. doi: 10.1002/pon.4389. Epub 2017 Feb 10. Psychooncology. 2018. PMID: 28129471
-
Prospective memory impairment in chemotherapy-exposed early breast cancer survivors: Preliminary evidence from a clinical test.J Psychosoc Oncol. 2016 Jul-Aug;34(4):291-304. doi: 10.1080/07347332.2016.1181133. Epub 2016 Apr 28. J Psychosoc Oncol. 2016. PMID: 27123566 Clinical Trial.
-
Chemotherapy-induced prospective memory impairment in patients with breast cancer.Psychooncology. 2013 Oct;22(10):2391-5. doi: 10.1002/pon.3291. Epub 2013 May 15. Psychooncology. 2013. PMID: 23674402
-
An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.Support Care Cancer. 2012 Jul;20(7):1361-75. doi: 10.1007/s00520-012-1445-4. Epub 2012 Apr 5. Support Care Cancer. 2012. PMID: 22476439 Review.
-
Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis.Neurosci Biobehav Rev. 2017 Dec;83:417-428. doi: 10.1016/j.neubiorev.2017.10.028. Epub 2017 Oct 29. Neurosci Biobehav Rev. 2017. PMID: 29092778 Review.
Cited by
-
Depression and Sleep Quality among Iranian Women with Breast Cancer.Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3433-3440. doi: 10.31557/APJCP.2021.22.11.3433. Asian Pac J Cancer Prev. 2021. PMID: 34837896 Free PMC article.
-
Event- and time-based prospective memory in hemodialysis patients.Ren Fail. 2020 Nov;42(1):1135-1141. doi: 10.1080/0886022X.2020.1835673. Ren Fail. 2020. PMID: 33179540 Free PMC article.
-
Study on anxiety, depression, and subjective wellbeing of patients with bladder cancer in their different chemotherapy stages.Front Psychol. 2023 Sep 13;14:1226712. doi: 10.3389/fpsyg.2023.1226712. eCollection 2023. Front Psychol. 2023. PMID: 37771813 Free PMC article.
-
Memory Impairments and Wellbeing in Breast Cancer Patients: A Systematic Review.J Clin Med. 2023 Nov 7;12(22):6968. doi: 10.3390/jcm12226968. J Clin Med. 2023. PMID: 38002583 Free PMC article. Review.
-
Self-reported cognitive function in older breast cancer survivors after chemotherapy treatment.Breast. 2025 Jun;81:104468. doi: 10.1016/j.breast.2025.104468. Epub 2025 Apr 1. Breast. 2025. PMID: 40184733 Free PMC article.
References
-
- Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China. Lancet Oncol 2014;15:e279–89. - PubMed
-
- Winocur G, Berman H, Nguyen M, et al. Neurobiological mechanisms of chemotherapy-induced cognitive impairment in a transgenic model of breast cancer. Neuroscience 2018;369:51–65. - PubMed
-
- Wefel JS, Saleeba AK, Buzdar AU, et al. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 2010;116:3348–56. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical